Contact: Gail Porter
gail.porter@nist.gov
301-975-3392
National Institute of Standards and Technology (NIST)

Biopharmaceutical Infrastructure Key to Lower Drug Development Costs

Caption: A new NIST-sponsored study found that the biopharmaceutical industry spend a total of $1,219 million on infrastructure technology?884 million on the R&D technology infrastructure including bioimaging, biomarkers, informatics, and gene expression and $335 million on infrastructure for commercial manufacturing and postmarket surveillance.

Credit: NIST

Usage Restrictions: None

Related news release: Biopharmaceutical infrastructure key to lower drug development costs